CervoMed Inc. Common Stock

CRVONASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
3.55 USD
↘ 0.14 (3.79%)AT CLOSE (11:59 AM EDT)
3.55
↗ 0.01 (0.14%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.55
↗ 0.01 (0.14%)
🔴Market: CLOSED

CervoMed Inc. Common Stock (CRVO) is currently trading at $3.55. CRVO shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Strong Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 2, 2026.

Open?$3.64
High?$3.69
Low?$3.45
Prev. Close?$3.69
Volume?310.1K
Avg. Volume?11.3M
VWAP?$3.53
Rel. Volume?0.03x
Bid / Ask
Bid?$3.05 × 100
Ask?$4.07 × 100
Spread?$1.02
Midpoint?$3.56
Valuation & Ratios
Market Cap?32.9M
Shares Out?11.0M
Float?5.8M
Float %?63.1%
P/E Ratio?N/A
P/B Ratio?3.10
EPS?-$3.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
15
Market Cap
32.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.cervomed.com
Listed
1996-06-18
Address
20 PARK PLAZA
BOSTON, MA 02116
Phone: (617) 744-4400
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
3
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.21Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.89%Elevated
Short Interest?343.8K
Days to Cover?1.0
Free Float5.8M
Avg Daily Volume1.0M
Settlement Date2026-06-15
Financial Health
Current Ratio?3.36Strong
Quick Ratio?3.36Strong
Cash Ratio?1.77Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
54
3.10FAIR▾
P/S?
Peers
100
S&P
3
15.73HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.8CHEAP▾
EV/Sales?
Peers
100
S&P
8
11.93HIGH▾
Returns & Efficiency
ROE?
S&P
3
-282.9%WEAK▾
ROA?
S&P
3
-198.8%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$24.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist